Wealth Enhancement Trust Services’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
CF
MBAM
Wealth Enhancement Trust Services's HCAT Position: Q3 2026 in Review
Wealth Enhancement Trust Services sold out of Health Catalyst (HCAT) in Q3 2026, closing a stake of 2 shares — an estimated $4 sold.
Wealth Enhancement Trust Services first reported a position in HCAT in Q2 2026 and held it in 1 quarter. The position peaked at $4 in Q2 2026. 76 funds tracked by Wall St. Rank hold HCAT as of Q3 2026.
- Wealth Enhancement Trust Services reported no remaining Health Catalyst position as of Q3 2026 after selling out during the quarter.
- Wealth Enhancement Trust Services sold 2 Health Catalyst shares in Q3 2026, an estimated $4.
- Wealth Enhancement Trust Services first reported a position in Health Catalyst in Q2 2026 and held it in 1 quarter.
- Wealth Enhancement Trust Services's Health Catalyst position peaked at $4 in Q2 2026.
- 76 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2026.
Based on Wealth Enhancement Trust Services's 13F filing for Q3 2026, filed 7 Oct 2026.